Basic mechanisms of motor fluctuations.
Level 5 - mechanism / opinion, no new human data
Narrative review and mechanism-based reasoning with no primary empirical data
What was done
This is a narrative review describing the mechanistic framework behind motor fluctuations that develop during long-term levodopa therapy in Parkinson's disease. The abstract does not report specific primary experimental methods, search protocols, or study cohorts.
What was found
The abstract reports no numerical data or quantitative outcomes. It categorizes the mechanisms driving motor fluctuations into three components: central pharmacokinetics (diminished presynaptic dopamine storage capacity leading to early wearing-off), peripheral pharmacokinetics (erratic gastric emptying and variable gut-to-blood and blood-brain barrier transport altering levodopa delivery), and pharmacodynamics (alterations in striatal dopamine receptor interactions contributing to erratic on-off phenomena in advanced disease).
Why it matters
It provides a structured pharmacokinetic and pharmacodynamic classification to understand why smooth responses to levodopa transition into predictable wearing-off and unpredictable fluctuations over time.
Limits
The abstract presents theoretical and physiological mechanisms without primary empirical data, sample size figures, statistical tests, or systematic review methodology.
Cited by
- supports In Parkinson's disease progression, surviving dopaminergic neurons lose the capacity to properly store dopamine, contributing to the need for more frequent levodopa dosing.